+++++++++++++++++++++++++ Norwood Abbey Limited (ASX:NAL) has exhibited its revolutionary laser device ("LAD") for the delivery of topically applied anaesthetics at the 6 th International Symposium on Paediatric Pain Management. Over 400 delegates are attending the symposium in Sydney from 15-19 th June 2003.
Norwood has received very significant interest from, Australian, New Zealand, North American and European delegates.
"This product will revolutionize children's health care as we know it. Imagine painless blood tests and needle procedures - children may actually like going to the doctor" said Renee Manworren, Paediatric Clinical Nurse and Manager of Pain Management, at the Childrens Medical Centre of Dallas in the USA.
The Children's Medical Centre of Dallas will commence using the LAD over the next couple of months and their response to the LAD has been tremendous.
The LAD system consists of a laser device and single-use disposable tip, and is intended to painlessly and temporarily alter the outer layer of the skin (stratum corneum) enhancing the penetration of topically applied drugs. Clinicians and nurses indicate that the slow onset of action of topically applied anaesthetics is the major barrier to use of these products prior to needle insertion procedures. The LAD reduces the time of anaesthesia onset from 30-60 minutes to just 5 minutes, enabling more patients to be treated with local anaesthetic prior to cannulation, venipuncture and other needle sticks.
Norwood is commencing large-scale manufacture of LAD units with Lightmed Corporation of Taiwan. Norwood expects to commence sales in North America within weeks. Executive Chairman, Peter Hansen, said "The Company believes that the LAD technology represents a breakthrough in transdermal drug delivery of topically applied local anaesthetics. According to Mr Hansen, there is also potential to use the LAD with many other pharmaceuticals including vaccines and anti-inflammatories.
To find out more about the company, visit www.norwoodabbey.com
AUSTRALIA COMPANY CONTACTS U.S. INVESTOR CONTACTS
Peter Hansen Lippert Heilshorn & Assoc. EXECUTIVE CHAIRMAN Kim Sutton Golodetz 613-9782-7333 [email protected] Bernie Romanin 613-9782-7333 212-838-3777 Director of Marketing Bruce Voss 613-9782-7333 310-691-7100 [email protected] www.lhai.com
NAL Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
